5Zeuzem S. Anti - viral activity of SCH 503034, a HCVproteaseinhibitor, administered as monotherapy in hepatitis C genotype - 1 ( HCV - 1 ) patients refractory to pegylated interferon(Peg-IFN-alpha) [J]. Hepatology,2005,42( Suppl 1) : 233A.
6O' Brien C. Randomized trial of valopicitabiue (NM283) alone orwith peg - interferon, vs. retreatment with peg - interferon plus ribavirin (PEGIFN/RBV) in hepatitis C patients with previous non- response to PEGIFN/RBV : first interim results[ J ]. Hepatology, 2005,42 ( Suppll ) : S234.
